Takeda Pharmaceutical Company Limited is a global biopharmaceutical company. The company focuses on oncology, inflammatory bowel diseases, and immunology. Takeda is committed to developing medicines for cancer patients and those with rare diseases, with a focus on patient needs and scientific rigor. The company also has a legacy in developing treatments for lysosomal storage disorders and a portfolio of commercial products, late-stage investigational therapies, and pipeline candidates. Takeda claims to have a strong presence in Belgium and a focus on therapeutic areas such as oncology, gastroenterology, and rare diseases.
Headquarters
Kota Jakarta Selatan Kuningan Timur Setia Budi Dki Jakarta
South Jakarta; Jakarta;
Postal Code: 12950
Contact Details: Purchase the PT Takeda Indonesia report to view the information.
Website: http://www.takeda.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service